Lives unaffected by cystic fibrosis

DRUG DEVELOPMENT PIPELINE

Back to the Drug Development Pipeline

TB Alliance

Pre-clinical

Pre-clinical

Therapeutic Approach

Anti-Infective

This program will identify and test potential treatments for infections caused by Mycobacterium abscessus (M. abscessus) and Mycobacterium avium complex (MAC), two types of nontuberculous mycobacteria (NTM). 

Status

Laboratory studies to identify and test these compounds are underway.

Sponsor

This program is sponsored by TB Alliance, in partnership with Johns Hopkins University, and is partially funded by the Cystic Fibrosis Foundation.



Contact us about TB Alliance >